![]() |
市場調查報告書
商品編碼
2133437
整形外科軟組織修復市場規模、佔有率和趨勢分析 |全球| 2026–2032 | 包括跟腱修復、肩迴旋肌修復裝置及其他5個類別Orthopedic Soft Tissue Repair Market Size, Share & Trends Analysis | Global | 2026-2032 | Includes: Achilles Tendon Repair, Rotator Cuff Repair Devices, and 5 more |
||||||
※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。
2025年,全球整形外科軟組織修復市場規模超過50億美元。預計該市場將以5.3%的複合年成長率成長,到2032年達到73億美元。
這份綜合報告涵蓋了全球骨科軟組織修復市場,包括肩迴旋肌修復、肩袖修復、肩關節軟骨修復、肱二頭肌腱固定、前十字韌帶 (ACL)/後十字韌帶 (PCL)重組、半月軟骨修復和整形外科關節鏡器械。
該分析包括銷售量、平均售價 (ASP)、治療次數、市場規模、成長趨勢、市場促進因素和阻礙因素、到 2032 年的市場預測以及追溯到 2022 年的歷史數據。它還涵蓋了近期併購、公司簡介、產品系列和主要參與者。
推動市場成長的因素包括運動傷害、錨釘和移植物的廣泛使用,以及生物材料加固和微創整形外科修復技術的持續創新。
市場概覽
全球整形外科軟組織修復市場包括用於修復和重組肩部、膝蓋、髖部、足部和踝部受損肌腱、韌帶、軟骨和關節唇組織的醫療設備。
這個市場涵蓋幾個主要的外科領域,包括跟腱修復和重組、肩關節軟骨肩迴旋肌修復和重組、肩胛盂唇修復、肱二頭肌腱固定、前十字韌帶 (ACL)/後十字韌帶 (PCL)重組、半月軟骨修復和髖關節鏡手術。
市場需求主要受活躍患者群體、運動傷害、老齡化相關性組織退化以及對微創整形外科手術的持續需求所驅動。軟組織修復產品廣泛應用於專業運動員護理、休閒運動醫學和常規整形外科診療的各個方面。
在預測期內,髖關節鏡手術預計將成為成長最快的領域。這一成長得益於髀臼診斷準確性的提高、可視化系統的進步以及使外科醫生能夠修復而非切除關節唇的專用髖關節鏡。
運動傷害的治療仍是整形外科軟組織修復市場的主要驅動力。肌腱和韌帶損傷在職業運動員和休閒運動員中都很常見,因此需要能夠有效固定、加速康復並維持治療效果的修復和重組器械。
運動醫學產業也正在透過夥伴關係、研發和教育推動創新。史密斯醫療(Smith & Nephew)與UFC的合作已延長至2026年,這就是領先企業與高水準運動組織合作的典範。這些合作關係能夠支持臨床試驗、教育計畫、獎學金以及先進復健技術的研發。
錨釘和移植物應用範圍廣泛,也推動了市場成長。縫合錨釘和移植物產品廣泛應用於肌腱和韌帶修復,包括肩關節、膝關節和髖關節手術。由於許多產品旨在應對多種適應症,製造商正在開發能夠滿足整形外科領域多樣化需求的通用系統。創新重點在於全縫合錨釘、生物相容性材料以及能夠促進骨植入並同時保持患者積極康復所需強度的系統。
門診治療模式的興起加劇了整形外科軟組織修復市場的價格壓力。門診手術中心(ASC)已成為部分整形外科手術的主要施行地點,而美國醫療保險和醫療服務中心(CMS)的政策調整正在加速這一轉變,這些調整將肌肉骨骼手術納入合格的醫療環境。
與醫院相比,門診手術中心(ASC)的營運成本較低,其報銷率約為醫院門診部的一半。這導致門診手術中心往往以成本主導,優先考慮效率和成本績效,而不是最新的高階醫療設備。因此,製造商必須在創新和價格可負擔性之間取得平衡。
報銷制度也限制了先進產品的應用。高階醫療設備、同種異體移植和合成支架會推高手術成本,而報銷額卻沒有相應增加。在打包支付模式下,昂貴的生物加固材料的使用可能僅限於預期長期收益明顯大於短期成本的情況。這種降低成本的思維模式可能會延緩先進修復系統的應用,即使臨床上有這種需求。
全球整形外科軟組織修復市場概覽
競爭分析
新興市場與新技術
市場趨勢
市場趨勢
標靶手術
目標市場
目標區域
關鍵分析更新
版本歷史記錄
全球整形外科軟組織修復市場概覽
The global orthopedic soft tissue repair market was valued at over $5 billion in 2025. It is expected to grow at a compound annual growth rate (CAGR) of 5.3%, reaching $7.3 billion by 2032.
This comprehensive report covers the global market for orthopedic soft tissue repair, including Achilles tendon repair, rotator cuff repair, shoulder labrum repair, biceps tenodesis, ACL/PCL reconstruction, meniscal repair and hip arthroscopy devices.
The analysis includes unit sales, average selling prices (ASPs), procedure numbers, market size, growth trends, market drivers and limiters, market forecasts through 2032, and historical data back to 2022. It also includes recent mergers and acquisitions, company profiles, product portfolios and leading competitors.
Growth is supported by sports-related injuries, broad use of anchors and grafts, and continued innovation in biologic augmentation and minimally invasive orthopedic repair techniques.
Market Overview
The global orthopedic soft tissue repair market includes devices used to repair and reconstruct damaged tendons, ligaments, cartilage and labral tissue across the shoulder, knee, hip, foot and ankle.
The market covers several major surgical segments, including Achilles tendon repair and reconstruction, rotator cuff repair and reconstruction, shoulder labrum repair, biceps tenodesis, ACL/PCL reconstruction, meniscal repair and hip arthroscopy.
Demand is supported by active patient populations, sports injuries, age-related tissue degeneration and the continued preference for minimally invasive orthopedic procedures. Soft tissue repair products are used across professional athlete care, recreational sports medicine and routine orthopedic practice.
Hip arthroscopy is expected to be the fastest-growing sector over the forecast period. Growth is supported by improved diagnosis of femoroacetabular impingement, better visualization systems and specialized hip arthroscopes that allow surgeons to repair the labrum rather than remove it.
Market Drivers
Sports-related injury treatment remains a key driver of the orthopedic soft tissue repair market. Tendon and ligament injuries are common among professional and recreational athletes, creating demand for repair and reconstruction devices that support strong fixation, faster recovery and durable outcomes.
The sports medicine industry also supports innovation through partnerships, research and education. Smith+Nephew's partnership with UFC, extended through 2026, is one example of how leading companies align with high-performance sports organizations. These relationships can support clinical trials, education programs, fellowships and development of advanced repair technologies.
Multiple applications for anchors and grafts also drive market growth. Suture anchors and grafting products are used across a wide range of tendon and ligament repairs, including shoulder, knee and hip procedures. Because many products are designed for several indications, manufacturers are developing versatile systems that can support multiple orthopedic applications. Innovation is focused on all-suture anchors, bio-integrative materials and systems that promote bone ingrowth while maintaining the strength needed for active patient recovery.
Market Limiters
The shift toward outpatient settings is creating pricing pressure in the orthopedic soft tissue repair market. Ambulatory Surgery Centers have become a major site for elective orthopedic procedures, and this shift is being accelerated by CMS policy changes that move musculoskeletal procedures into ASC-eligible settings.
ASCs operate with lower overhead than hospitals and are reimbursed at roughly half the rate of hospital outpatient departments. This creates a cost-driven environment where facilities often prioritize efficiency and value over the newest premium hardware. Manufacturers must therefore balance innovation with affordability.
Reimbursement also limits adoption of advanced products. Premium devices, allografts and synthetic scaffolds can increase procedure cost without a corresponding increase in payment. In bundled payment environments, the use of higher-priced biologic augmentation may be restricted to cases where the expected long-term benefit clearly outweighs the immediate cost. This cost-saving mindset can slow adoption of advanced repair systems despite clinical interest.
Market Coverage and Data Scope
The report is designed to help readers evaluate how sports medicine demand, arthroscopic innovation, biologic augmentation, ASC adoption, reimbursement pressure and procedure growth are shaping the global orthopedic soft tissue repair market.
Markets Covered and Segmentation
Each segment is analyzed through relevant quantitative measures, including market size, market shares, procedure numbers, market forecasts, growth rates, units sold and average selling prices.
Competitive Analysis
Arthrex remained the dominant competitor in the global orthopedic soft tissue repair market, supported by the breadth and depth of its sports medicine portfolio. The company competes across nearly every major segment, including rotator cuff repair, shoulder instability, ACL reconstruction, meniscal repair and related fixation technologies.
In rotator cuff repair, Arthrex's SpeedBridge construct, FiberTak RC soft anchors and SwiveLock knotless fixation system support widely used double-row repair techniques. The company also offers CuffMend for augmented repairs, using a decellularized dermal allograft with FiberStitch RC implants and PushLock anchors for more challenging cases.
Smith+Nephew is differentiated by its focus on biological healing. Its REGENETEN Bioinductive Implant is central to this strategy and is used as a collagen scaffold to support tendon-like tissue formation. The company has expanded REGENETEN beyond rotator cuff applications into gluteus medius, Achilles tendon and other tendinopathies.
DePuy Synthes competes through its Mitek Sports Medicine franchise, with products across ACL reconstruction, rotator cuff repair, meniscal repair and hip arthroscopy. The planned spin-off from Johnson & Johnson introduces near-term uncertainty, but may also allow a more focused sports medicine strategy under dedicated leadership.
Technology and Practice Trends
All-suture anchors are becoming more important across soft tissue repair. These products can reduce implant profile while maintaining fixation strength, supporting their use in shoulder, labral and other soft tissue procedures.
Bio-integrative and biologic augmentation products are gaining attention in complex repairs. These products are designed to support healing, tendon regeneration or bone ingrowth, especially in patients with poor tissue quality or higher retear risk.
Rotator cuff repair continues to be a major innovation area. Double-row constructs, knotless fixation, soft anchors and augmentation systems are being used to improve repair strength and support more predictable recovery.
Hip arthroscopy is expanding as surgeons gain better tools for femoroacetabular impingement and labral repair. Advanced visualization and specialized access devices allow more precise work in the deep hip joint space.
Meniscal repair is shifting toward more advanced repair techniques. Devices that allow controlled stitch placement and access to difficult compartments can expand repair options for tear types that may previously have been difficult to treat.
ASC adoption is shaping product design and purchasing. Manufacturers are under pressure to offer systems that are efficient, cost-effective and suitable for high-throughput outpatient orthopedic settings.
Geography
This report provides global coverage across North America, Europe, Asia-Pacific, Latin America, the Middle East, and Africa.
How large is the global orthopedic soft tissue repair market, and how is it expected to grow through 2032?
How are Achilles tendon repair, rotator cuff repair, shoulder labrum repair, biceps tenodesis, ACL/PCL reconstruction, meniscal repair and hip arthroscopy performing globally?
How are unit sales, average selling prices, procedure numbers and market values changing over time?
Why is hip arthroscopy expected to be the fastest-growing sector within orthopedic soft tissue repair?
How are all-suture anchors, grafts, biologic augmentation and bio-integrative materials changing repair techniques?
How are ASCs and reimbursement pressure affecting adoption of premium devices and grafting materials?
How do sports injuries and active patient populations support demand for repair and reconstruction products?
Which companies lead the market, and how are Arthrex, Smith+Nephew and DePuy Synthes positioned?
The Global Orthopedic Soft Tissue Repair Market Report from iData Research answers these questions with detailed market sizing, ASP trends, procedure data, forecasts and competitive share insights. Use it to evaluate demand, benchmark leading competitors, assess technology adoption and plan for growth across the global orthopedic soft tissue repair market.
Global Orthopedic Soft Tissue Repair Market Overview
Competitive Analysis
Emerging Markets And Technologies
Market Trends
Market Developments
Procedures Included
Markets Included
Regions Included
Key Analysis Updates
Version History
Global Orthopedic Soft Tissue Repair Market Overview